Wolf Rogowski is a health economist at the Helmholtz Center Munich, Institute of Health Economics and Health Care Management in Germany. Since August 2009, he has been head of the institute’s research unit “Translational Health Economics”. He holds a Ph.D. from Ludwig-Maximilians Universität in Munich and has held visiting fellowships at the Centre of Health Economics at the University of York (UK), the Hastings Center in Garrison, New York (USA) and the Harvard School of Public Health, Boston (USA). Focusing on genetic testing and personalized medicine, Wolf serves as a member of the European Society for Human Genetics’ Professional and Public Policy Committee and the scientific advisory board of the Journal of Community Genetics.
Wolf explores the process of translational medicine from a health economics perspective. This includes: the application of cost-effectiveness and value of information analysis to new health technologies; the empirical and theoretical assessment of methods and procedures applied in decision making; and the development of instruments for decision support. He has a particular interest in the intersection of ethics and economics in medical innovation.
Priority Setting for New Genetic Tests – Experiences form the EuroGentest Project
This talk takes a look at decisions that need to be made about which tests should be funded by public health care payers, exploring the topic of priority setting for genetic tests.